Citations

Clear

86 citation(s) found for "Smith, David".

Noncatalytic Role of the FKBP52 Peptidyl-Prolyl Isomerase Domain in the Regulation of Steroid Hormone Signaling
Cox, Marc B. , Tardif, Heather L., Büchner, Johannes , Smith, David F. , Riggs, Daniel L. , Heßling, Martin

Mayo Clinic

Molecular and Cellular Biology | October 15, 2007 | Volume: 27 | Issue: 24 | Pages: 8658-8669

10.1128/mcb.00985-07 | PMID 17938211 Get It

FK506-Binding Protein 52 Phosphorylation: A Potential Mechanism for Regulating Steroid Hormone Receptor Activity
Cox, Marc B. , Schumacher, Felix , Büchner, Johannes , Smith, David F. , Riggs, Daniel L. , Heßling, Martin

Mayo Clinic

Molecular Endocrinology | August 23, 2007 | Volume: 21 | Issue: 12 | Pages: 2956-2967

10.1210/me.2006-0547 | PMID 17717070 Get It

Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity
Hong, Ji-Young, Kim, Sung Tae , Tranguch, Susanne , Smith, David F. , Dey, Sudhansu K.

Mayo Clinic

Reproduction | February 16, 2007 | Volume: 133 | Issue: 2 | Pages: 395-403

10.1530/rep-06-0180 | PMID 17307907 Get It

Abstract FKBP52 is a member of the FK506-binding family of immunophilins and serves as a co-chaperone for steroid hormone nuclear receptors to govern appropriate hormone action in target tissues. Male mice missing Fkbp52 are infertile, and this infertility has been ascribed to compromised sensitivity of the anterior prostate, external genitalia, and other accessory sex organs to androgen. Here, we show additional defects contributing to infertility. We found that epididymal Fkbp52−/− sperm are sparse often with aberrant morphology, and they have reduced fertilizing capacity. This phenotype, initially observed in null males on a C57BL/6/129 background, is also maintained on a CD1 background. Expression studies show that while FKBP52 and androgen receptor are co-expressed in similar cell types in the epididymis, FKBP52 is also present in epididymal sperm flagella. Collectively, our results suggest that reduced number and abnormal morphology contribute to compromised fertilizing capacity of Fkbp52−/− sperm. This study is clinically relevant because unraveling the role of immunophilin signaling in male fertility will help identify new targets for male contraceptives and/or alleviate male infertility.
Human TopBP1 Ensures Genome Integrity during Normal S Phase
Kim, Ja‐Eun , McAvoy, Sarah , Smith, David I., Smith, David I., Chen, Junjie

Mayo Clinic

Molecular and Cellular Biology | November 28, 2005 | Volume: 25 | Issue: 24 | Pages: 10907-10915

10.1128/mcb.25.24.10907-10915.2005 | PMID 16314514 Get It

Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Lu, Karen H. , Patterson, Andrea P., Marquez, Rebecca T., Atkinson, E. Neely, Baggerly, Keith, Ramoth, Lance R., Rosen, Daniel , Hellström, Ingegerd, Smith, David, Hartmann, Lynn C. , Fishman, David A. , Schmandt, Rosemarie , Whitaker, Regina S. , Bast, Robert C. , Wang, Lin , Liu, Jinsong , Smith, David, Berchuck, Andrew , Gershenson, David M. , Mills, Gordon B. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 10 | Issue: 10 | Pages: 3291-3300

10.1158/1078-0432.ccr-03-0409 | PMID 15161682 Get It

Abstract Purpose: Advanced-stage epithelial ovarian cancer has a poor prognosis with long-term survival in less than 30% of patients. When the disease is detected in stage I, more than 90% of patients can be cured by conventional therapy. Screening for early-stage disease with individual serum tumor markers, such as CA125, is limited by the fact that no single marker is up-regulated and shed in adequate amounts by all ovarian cancers. Consequently, use of multiple markers in combination might detect a larger fraction of early-stage ovarian cancers. Experimental Design: To identify potential candidates for novel markers, we have used Affymetrix human genome arrays (U95 series) to analyze differences in gene expression of 41,441 known genes and expressed sequence tags between five pools of normal ovarian surface epithelial cells (OSE) and 42 epithelial ovarian cancers of different stages, grades, and histotypes. Recursive descent partition analysis (RDPA) was performed with 102 probe sets representing 86 genes that were up-regulated at least 3-fold in epithelial ovarian cancers when compared with normal OSE. In addition, a panel of 11 genes known to encode potential tumor markers [mucin 1, transmembrane (MUC1), mucin 16 (CA125), mesothelin, WAP four-disulfide core domain 2 (HE4), kallikrein 6, kallikrein 10, matrix metalloproteinase 2, prostasin, osteopontin, tetranectin, and inhibin] were similarly analyzed. Results: The 3-fold up-regulated genes were examined and four genes [Notch homologue 3 (NOTCH3), E2F transcription factor 3 (E2F3), GTPase activating protein (RACGAP1), and hematological and neurological expressed 1 (HN1)] distinguished all tumor samples from normal OSE. The 3-fold up-regulated genes were analyzed using RDPA, and the combination of elevated claudin 3 (CLDN3) and elevated vascular endothelial growth factor (VEGF) distinguished the cancers from normal OSE. The 11 known markers were analyzed using RDPA, and a combination of HE4, CA125, and MUC1 expression could distinguish tumor from normal specimens. Expression at the mRNA level in the candidate markers was examined via semiquantitative reverse transcription-PCR and was found to correlate well with the array data. Immunohistochemistry was performed to identify expression of the genes at the protein level in 158 ovarian cancers of different histotypes. A combination of CLDN3, CA125, and MUC1 stained 157 (99.4%) of 158 cancers, and all of the tumors were detected with a combination of CLDN3, CA125, MUC1, and VEGF. Conclusions: Our data are consistent with the possibility that a limited number of markers in combination might identify >99% of epithelial ovarian cancers despite the heterogeneity of the disease.
Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
Marquez, Rebecca T., Baggerly, Keith, Patterson, Andrea P., Broaddus, Russell, Atkinson, E. Neely, Smith, David I., Hartmann, Lynn C. , Fishman, David A. , Whitaker, Regina S. , Bast, Robert C. , Lu, Karen H. , Liu, Jinsong , Frumovitz, Michael , Smith, David I., Berchuck, Andrew , Gershenson, David M. , Mills, Gordon B. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 11 | Issue: 17 | Pages: 6116-6126

10.1158/1078-0432.ccr-04-2509 | PMID 16144910 Get It

Abstract Purpose: Epithelial ovarian cancers are thought to arise from flattened epithelial cells that cover the ovarian surface or that line inclusion cysts. During malignant transformation, different histotypes arise that resemble epithelial cells from normal fallopian tube, endometrium, and intestine. This study compares gene expression in serous, endometrioid, clear cell, and mucinous ovarian cancers with that in the normal tissues that they resemble. Experimental Design: Expression of 63,000 probe sets was measured in 50 ovarian cancers, in 5 pools of normal ovarian epithelial brushings, and in mucosal scrapings from 4 normal fallopian tube, 5 endometrium, and 4 colon specimens. Using rank-sum analysis, genes whose expressions best differentiated the ovarian cancer histotypes and normal ovarian epithelium were used to determine whether a correlation based on gene expression existed between ovarian cancer histotypes and the normal tissues they resemble. Results: When compared with normal ovarian epithelial brushings, alterations in serous tumors correlated with those in normal fallopian tube (P = 0.0042) but not in other normal tissues. Similarly, mucinous cancers correlated with those in normal colonic mucosa (P = 0.0003), and both endometrioid and clear cell histotypes correlated with changes in normal endometrium (P = 0.0172 and 0.0002, respectively). Mucinous cancers displayed the greatest number of alterations in gene expression when compared with normal ovarian epithelial cells. Conclusion: Studies at a molecular level show distinct expression profiles of different histologies of ovarian cancer and support the long-held belief that histotypes of ovarian cancers come to resemble normal fallopian tube, endometrial, and colonic epithelium. Several potential molecular markers for mucinous ovarian cancers have been identified.
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
Hartmann, Lynn C. , Lu, Karen H. , Linette, Gerald P. , Cliby, William A. , Kalli, Kimberly R., Bast, Robert C. , Stec, James , Iartchouk, Natalia, Smith, David I., Hoersch, Sebastian, Shridhar, Viji , Lillie, James W., Clark, Edwin, Damokosh, Andrew I., Gershenson, David M. , Smith, David I., Ross, Jeffrey S. , Kaufmann, Scott H. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 11 | Issue: 6 | Pages: 2149-2155

10.1158/1078-0432.ccr-04-1673 | PMID 15788660 Get It

Abstract Purpose: Women with advanced epithelial ovarian cancer are routinely treated with platinum-paclitaxel chemotherapy following cytoreductive surgery, yet only ∼20% achieve long-term disease-free survival. We hypothesized that differences in gene expression before treatment could distinguish patients with short versus long time to recurrence after administration of platinum-paclitaxel combination chemotherapy. Experimental Design: To test this hypothesis, gene expression profiling of 79 primary surgically resected tumors from women with advanced-stage, high-grade epithelial ovarian cancer was done using cDNA microarrays containing 30,721 genes. Supervised learning algorithms were applied in an effort to develop a binary classifier that could discriminate women at risk for early (≤21 months) versus late (>21 months) relapse after initial chemotherapy. Results: A 14-gene predictive model was developed using a set of training samples (n = 51) and subsequently tested using an independent set of test samples (n = 28). This model correctly predicted the outcome of 24 of the 28 test samples (86% accuracy) with 95% positive predictive value for early relapse. Conclusions: Predictive markers for early recurrence can be identified for platinum-paclitaxel combination chemotherapy in primary ovarian carcinoma. The proposed 14-gene model requires further validation.
Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation
Tranguch, Susanne , Cheung‐Flynn, Joyce , Daikoku, Takiko , Prapapanich, Viravan, Cox, Marc B. , Xie, Huirong , Smith, David F. , Wang, Haibin , Das, Sanjoy K. , Dey, Sudhansu K.

Mayo Clinic

Proceedings of the National Academy of Sciences | September 21, 2005 | Volume: 102 | Issue: 40 | Pages: 14326-14331

10.1073/pnas.0505775102 | PMID 16176985 Get It

Embryo implantation in the uterus is a critical step in mammalian reproduction, requiring preparation of the uterus receptive to blastocyst implantation. Uterine receptivity, also known as the window of implantation, lasts for a limited period, and it is during this period blastocysts normally implant. Ovarian steroid hormones estrogen and progesterone (P 4 ) are the primary regulators of this process. The immunophilin FKBP52 serves as a cochaperone for steroid hormone nuclear receptors to govern appropriate hormone action in target tissues. Here we show a critical role for FKBP52 in mouse implantation. This immunophilin has unique spatiotemporal expression in the uterus during implantation, and females missing the Fkbp52 gene have complete implantation failure due to lack of attainment of uterine receptivity. The overlapping uterine expression of FKBP52 with nuclear progesterone receptor (PR) in wild-type mice together with reduced P 4 binding to PR, attenuated PR transcriptional activity and down-regulation of several P 4 -regulated genes in uteri of Fkbp52 -/- mice, establishes this cochaperone as a critical regulator of uterine P 4 function. Interestingly, ovulation, another P 4 -mediated event, remains normal. Collectively, the present investigation provides evidence for an in vivo role for this cochaperone in regulating tissue-specific hormone action and its critical role in uterine receptivity for implantation.
Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes
Pett, Mark R., Alazawi, William , Roberts, Ian , Dowen, Sally E., Smith, David I., Stanley, Margaret , Coleman, Nicholas , Smith, David I.

Mayo Clinic

Cancer Research | September 20, 2005 | Volume: 64 | Issue: 4 | Pages: 1359-1368

10.1158/0008-5472.can-03-3214 | PMID 14973079 Get It

Abstract Whereas two key steps in cervical carcinogenesis are integration of high-risk human papillomavirus (HR-HPV) and acquisition of an unstable host genome, the temporal association between these events is poorly understood. Chromosomal instability is induced when HR-HPV E7 oncoprotein is overexpressed from heterologous promoters in vitro. However, it is not known whether such events occur at the “physiologically” elevated levels of E7 produced by deregulation of the homologous HR-HPV promoter after integration. Indeed, an alternative possibility is that integration in vivo is favored in an already unstable host genome. We have addressed these issues using the unique human papillomavirus (HPV) 16-containing cervical keratinocyte cell line W12, which was derived from a low-grade squamous intraepithelial lesion and thus acquired HPV16 by “natural” infection. Whereas W12 at low passage contains HPV16 episomes only, long-term culture results in the emergence of cells containing integrated HPV16 only. We show that integration of HPV16 in W12 is associated with 3′ deletion of the E2 transcriptional repressor, resulting in deregulation of the homologous promoter of the integrant and an increase in E7 protein levels. We further demonstrate that high-level chromosomal instability develops in W12 only after integration and that the forms of instability observed correlate with the physical state of HPV16 DNA and the level of E7 protein. Whereas intermediate E7 levels are associated with numerical chromosomal abnormalities, maximal levels are associated with both numerical and structural aberrations. HR-HPV integration is likely to be a critical event in cervical carcinogenesis, preceding the development of chromosomal abnormalities that drive malignant progression.
Physiological Role for the Cochaperone FKBP52 in Androgen Receptor Signaling
Cheung‐Flynn, Joyce , Prapapanich, Viravan, Cox, Marc B. , Suárez‐Quian, Carlos A. , Riggs, Daniel L. , Smith, David F.

Mayo Clinic

Molecular Endocrinology | April 15, 2005 | Volume: 19 | Issue: 6 | Pages: 1654-1666

10.1210/me.2005-0071 | PMID 15831525 Get It

AbstractMolecular chaperones mediate multiple aspects of steroid receptor function, but the physiological importance of most receptor-associated cochaperones has not been determined. To help fill this gap, we targeted for disruption the mouse gene for the 52-kDa FK506 binding protein, FKBP52, a 90-kDa heat shock protein (Hsp90)-binding immunophilin found in steroid receptor complexes. A mouse line lacking FKBP52 (52KO) was generated and characterized. Male 52KO mice have several defects in reproductive tissues consistent with androgen insensitivity; among these defects are ambiguous external genitalia and dysgenic prostate. FKBP52 and androgen receptor (AR) are coexpressed in prostate epithelial cells of wild-type mice. However, FKBP52 and AR are similarly coexpressed in testis even though testis morphology and spermatogenesis in 52KO males are usually normal. Molecular studies confirm that FKBP52 is a component of AR complexes, and cellular studies in yeast and human cell models demonstrate that FKBP52 can enhance AR-meditated transactivation. AR enhancement requires FKBP52 peptidylprolyl isomerase activity as well as Hsp90-binding ability, and enhancement probably relates to an affect of FKBP52 on AR-folding pathways. In the presence of FKBP52, but not other cochaperones, the function of a minimally active AR point mutant can be dramatically restored. We conclude that FKBP52 is an AR folding factor that has critically important physiological roles in some male reproductive tissues.